Search

Author/Creator Diede, Scott J.

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients. (March 2020)

Authors:
Pearson, Andrew D.J.; Rossig, Claudia; Lesa, Giovanni; Diede, Scott J.; Weiner, Susan; Anderson, John; Gray, Juliet; Geoerger, Birgit; Minard-Colin, Veronique; Marshall, Lynley V.; Smith, Malcolm; Sondel, Paul; Bajars, Marcis; Baldazzi, Claudia; Barry, Elly; Blackman, Sam; Blanc, Patricia; Capdev...
Journal:
European journal of cancer
Issue:
Volume 127(2020)
Page Start:
52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers. (1st February 2020)

Authors:
Joseph, Richard W.; Shillington, Alicia C.; Lee, Todd A.; Macahilig, Cynthia P.; Diede, Scott J.; Dave, Vaidehi; Harshaw, Qing; Scherrer, Emilie; Liu, Frank Xiaoqing
Journal:
Journal of medical economics
Issue:
Volume 23:Number 2(2020)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation. (January 2022)

Authors:
Maio, Michele; Carlino, Matteo S.; Joshua, Anthony M.; McWhirter, Elaine; Ribas, Antoni; Ascierto, Paolo A.; Miller, Wilson H.; Butler, Marcus O.; Ferrucci, Pier Francesco; Zielinski, Robert R.; Del Vecchio, Michele; Gasal, Eduard; Ghori, Razi; Diede, Scott J.; Croydon, Elizabeth; Hamid, Omid
Journal:
European journal of cancer
Issue:
Volume 160(2022)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006. (November 2021)

Authors:
Hamid, Omid; Robert, Caroline; Daud, Adil; Carlino, Matteo S.; Mitchell, Tara C.; Hersey, Peter; Schachter, Jacob; Long, Georgina V.; Hodi, F. Stephen; Wolchok, Jedd D.; Arance, Ana; Grob, Jean Jacques; Joshua, Anthony M.; Weber, Jeffrey S.; Mortier, Laurent; Jensen, Erin; Diede, Scott J.; Moreno...
Journal:
European journal of cancer
Issue:
Volume 157(2021)
Page Start:
391
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma. (February 2021)

Authors:
Robert, Caroline; Hwu, Wen-Jen; Hamid, Omid; Ribas, Antoni; Weber, Jeffrey S.; Daud, Adil I.; Hodi, F. Stephen; Wolchok, Jedd D.; Mitchell, Tara C.; Hersey, Peter; Dronca, Roxana; Joseph, Richard W.; Boutros, Celine; Min, Le; Long, Georgina V.; Schachter, Jacob; Puzanov, Igor; Dummer, Reinhard; L...
Journal:
European journal of cancer
Issue:
Volume 144(2021)
Page Start:
182
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial. Issue 7 (30th March 2018)

Authors:
Pinto, Navin; DuBois, Steven G.; Marachelian, Araz; Diede, Scott J.; Taraseviciute, Agne; Glade Bender, Julia L.; Tsao‐Wei, Denice; Groshen, Susan G.; Reid, Joel M.; Haas‐Kogan, Daphne A.; Reynolds, C. Patrick; Kang, Min H.; Irwin, Meredith S.; Macy, Margaret E.; Villablanca, Judith G.; Matthay, ...
Journal:
Pediatric blood & cancer
Issue:
Volume 65:Issue 7(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination. Issue 1 (1st January 2023)

Authors:
Arance, Ana; de la Cruz-Merino, Luis; Petrella, Teresa M.; Jamal, Rahima; Ny, Lars; Carneiro, Ana; Berrocal, Alfonso; Márquez-Rodas, Ivan; Spreafico, Anna; Atkinson, Victoria; Costa Svedman, Fernanda; Mant, Andrew; Khattak, Muhammad A.; Mihalcioiu, Catalin; Jang, Sekwon; Cowey, C. Lance; Smith, A...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 1(2023)
Page Start:
75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. Issue 3 (23rd August 2022)

Authors:
Chesney, Jason A.; Ribas, Antoni; Long, Georgina V.; Kirkwood, John M.; Dummer, Reinhard; Puzanov, Igor; Hoeller, Christoph; Gajewski, Thomas F.; Gutzmer, Ralf; Rutkowski, Piotr; Demidov, Lev; Arenberger, Petr; Shin, Sang Joon; Ferrucci, Pier Francesco; Haydon, Andrew; Hyngstrom, John; van Thiene...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 3(2023)
Page Start:
528
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗